BRPI0409653A - 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica - Google Patents
3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnicaInfo
- Publication number
- BRPI0409653A BRPI0409653A BRPI0409653-3A BRPI0409653A BRPI0409653A BR PI0409653 A BRPI0409653 A BR PI0409653A BR PI0409653 A BRPI0409653 A BR PI0409653A BR PI0409653 A BRPI0409653 A BR PI0409653A
- Authority
- BR
- Brazil
- Prior art keywords
- diphenylpropylamines
- halogen
- alkyl
- tolterodine
- optionally substituted
- Prior art date
Links
- KISZTEOELCMZPY-UHFFFAOYSA-N 3,3-diphenylpropylamine Chemical class C=1C=CC=CC=1C(CCN)C1=CC=CC=C1 KISZTEOELCMZPY-UHFFFAOYSA-N 0.000 title abstract 6
- 229910052736 halogen Inorganic materials 0.000 title abstract 5
- 125000005843 halogen group Chemical group 0.000 title abstract 3
- 230000001022 anti-muscarinic effect Effects 0.000 title abstract 2
- OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 title abstract 2
- 229960004045 tolterodine Drugs 0.000 title abstract 2
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46537203P | 2003-04-25 | 2003-04-25 | |
| PCT/IB2004/001333 WO2004096751A1 (en) | 2003-04-25 | 2004-04-15 | Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0409653A true BRPI0409653A (pt) | 2006-04-25 |
Family
ID=33418235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0409653-3A BRPI0409653A (pt) | 2003-04-25 | 2004-04-15 | 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20050004223A1 (enExample) |
| EP (1) | EP1620389A1 (enExample) |
| JP (1) | JP2006524677A (enExample) |
| BR (1) | BRPI0409653A (enExample) |
| CA (1) | CA2523226A1 (enExample) |
| MX (1) | MXPA05011509A (enExample) |
| WO (1) | WO2004096751A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0957073A1 (en) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
| BR0206207A (pt) * | 2001-10-26 | 2003-12-23 | Pharmacia & Up John Company | Compostos de amÈnio quaternário e seu uso como agentes antimuscarìnicos |
| DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
| CA2523226A1 (en) * | 2003-04-25 | 2004-11-11 | Pharmacia & Upjohn Company Llc | Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity |
| KR101029643B1 (ko) | 2004-07-24 | 2011-04-15 | 일동제약주식회사 | 엔-메틸-3,3-디페닐프로필아민의 제조방법 |
| KR100647068B1 (ko) | 2005-09-15 | 2006-11-23 | 하나제약 주식회사 | 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법 |
| CN100430370C (zh) * | 2006-11-03 | 2008-11-05 | 华东理工大学 | 一种丙胺衍生物及其在制备托莫西汀中的应用 |
| GB2455176A (en) | 2007-11-01 | 2009-06-03 | Acucela Inc | Amine derivatives useful for treating ophthalmic diseases and disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8800207D0 (sv) | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
| SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| EP0957073A1 (en) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
| BR0206207A (pt) * | 2001-10-26 | 2003-12-23 | Pharmacia & Up John Company | Compostos de amÈnio quaternário e seu uso como agentes antimuscarìnicos |
| CA2523226A1 (en) * | 2003-04-25 | 2004-11-11 | Pharmacia & Upjohn Company Llc | Halogen substituted 3,3-diphenylpropylamines (tolterodine) having antimuscarinic activity |
-
2004
- 2004-04-15 CA CA002523226A patent/CA2523226A1/en not_active Abandoned
- 2004-04-15 JP JP2006506554A patent/JP2006524677A/ja not_active Withdrawn
- 2004-04-15 EP EP04727624A patent/EP1620389A1/en not_active Withdrawn
- 2004-04-15 WO PCT/IB2004/001333 patent/WO2004096751A1/en not_active Ceased
- 2004-04-15 BR BRPI0409653-3A patent/BRPI0409653A/pt not_active IP Right Cessation
- 2004-04-15 MX MXPA05011509A patent/MXPA05011509A/es not_active Application Discontinuation
- 2004-04-26 US US10/832,555 patent/US20050004223A1/en not_active Abandoned
-
2005
- 2005-08-25 US US11/212,330 patent/US7119121B2/en not_active Expired - Fee Related
-
2006
- 2006-08-24 US US11/466,814 patent/US7291648B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1620389A1 (en) | 2006-02-01 |
| US7291648B2 (en) | 2007-11-06 |
| US7119121B2 (en) | 2006-10-10 |
| US20050004223A1 (en) | 2005-01-06 |
| CA2523226A1 (en) | 2004-11-11 |
| JP2006524677A (ja) | 2006-11-02 |
| WO2004096751A1 (en) | 2004-11-11 |
| US20060004106A1 (en) | 2006-01-05 |
| MXPA05011509A (es) | 2005-12-15 |
| US20060281812A1 (en) | 2006-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414514A (pt) | uso de um composto, composto, e, composições farmacêuticas | |
| TW200720226A (en) | Fluorinated derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the β2 adrenergic receptor | |
| GEP20125379B (en) | 2 -pyridine carboxamide derivatives as sodium channel modulators | |
| BR0011324A (pt) | Agonista de adrenoceptores beta 2 | |
| BRPI0417323A (pt) | indóis, 1h-indazóis, 1,2-benzisoxazóis, e 1,2-benzisotiazóis, composto, composição farmacêutica e usos dos mesmos | |
| BRPI0508540B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA200700501A1 (ru) | Композиция (варианты) и способ для лечения гиперпролиферативных процессов, способ лечения рака (варианты) и способ получения твёрдой дисперсии вещества | |
| BR0214342A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| MA29213B1 (fr) | Quinolones a substitution macrolones - amino | |
| BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
| BR0206561A (pt) | Uso de um composto, método de tratamento ou prevenção de disfunções, uso ou método, método de neuroproteção e composto | |
| JP2012505879A5 (enExample) | ||
| BR0215650A (pt) | Preparação combinada para a administração simultânea, separada, ou sequencial no tratamento do câncer, método para o tratamento do câncer, uso de pelo menos um composto, e, composição farmacêutica | |
| BRPI0409653A (pt) | 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica | |
| DE602006012725D1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
| WO2010005580A3 (en) | Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity | |
| BRPI0414780A (pt) | composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia da dor em um animal de sangue quente, e para preparar um composto | |
| BRPI0519280A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto | |
| BR0308133A (pt) | Forma polimórfica cristalina de cloridrato de irinotecan | |
| BR0315958A (pt) | Composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto | |
| BRPI0515860B8 (pt) | derivados de tetralin e indano, seus usos, e composição farmacêutica | |
| BRPI0414644A (pt) | composto, composições farmacêuticas, e, uso de um composto | |
| UA81640C2 (ru) | Противомикобактериальные соединения, способ их получения, фармацевтическая композиция на их основе | |
| AR037611A1 (es) | Compuestos derivados de amino-tetralina, su uso, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| RU2007144076A (ru) | Новое производное лактама |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |